lv1
A worker handles a bottle of Merck & Co. and Ridgeback Biotherapeutics LPs Molnupiravir antiviral medication in a warehouse in Shoham, Israel, on Jan. 18, 2022. A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial...
Buyer beware: molnupiravir may damage DNA J. V. van Schalkwyk Published in British medical journal 4 November 2021 Medicine TLDR There is a certain irony that vaccine shy people who have believed the untruth that vaccines against SARS-CoV-2 alter DNA seem poised to reach for a perceived “alternative” that may actually alter their...
Spread Awareness About the Deadly Side Effects of Molnupiravir
©2022. Molnupiravir-Stop All Rights Reserved.
